Amanote Research
Register
Sign In
Cost-Effectiveness of Indacaterol/Glycopyrronium in Comparison With Salmeterol/Fluticasone Combination for Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease: A LANTERN Population Analysis From Singapore
Singapore Medical Journal
- Singapore
doi 10.11622/smedj.2018022
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Date
July 1, 2018
Authors
A Tee
WL Chow
C Burke
B Guruprasad
Publisher
Singapore Medical Journal
Related search
Prs42 - Cost-Effectiveness of Indacaterol/Glycopyrronium in the Treatment of Chronic Obstructive Pulmonary Disease in Brazil
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Indacaterol/Glycopyrronium Is Cost-Effective Compared to Salmeterol/Fluticasone in COPD: FLAME-based Modelling in a Swedish Population
Respiratory Research
Pulmonary
Respiratory Medicine
Cost-Effectiveness of Tiotropium Versus Glycopyrronium in Moderate to Very Severe Chronic Obstructive Pulmonary Disease in Canada, Spain, Sweden, and the UK
ClinicoEconomics and Outcomes Research
Health Policy
Economics
Econometrics
Finance
Cost-Effectiveness of Combination Fluticasone Propionate–salmeterol 250/50 Μg Versus Salmeterol in Severe COPD Patients
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Cost-Effectiveness Analysis of Indacaterol/Glycopirronium (QVA149) as a Maintenance Bronchodilator Treatment in Adult Patients With Chronic Obstructive Pulmonary Disease in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Letter to the Editor: Indacaterol/Glycopyrronium/Mometasone Furoate Compared With Salmeterol/Fluticasone Propionate in Patients With Asthma: A Randomized Controlled Cross-Over Study
Respiratory Research
Pulmonary
Respiratory Medicine
Respiratory and Cardiovascular Effects of Combined Therapy With Indacaterol and Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease
Pulmonologiya
Pulmonary
Respiratory Medicine
Clinical Benefit of Fixed-Dose Dual Bronchodilation With Glycopyrronium and Indacaterol Once Daily in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review
International Journal of COPD
Environmental
Public Health
Health Policy
Medicine
Pulmonary
Respiratory Medicine
Occupational Health
